Peanut allergy associated with vaccinations leads to profit for patch-peddling pharmaceutical company
 |
(NaturalNews) A French pharmaceutical company is hoping to reap massive profits from a new drug patch that it says treats a common food allergy caused by vaccines. The DBV Technologies SA Viaskin Peanut patch for peanut allergy currently holds a market value of $1 billion, according… |
Source: Natural News Feed
There are no comments yet
Why not be the first